The ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA study started up in late 2022. It is conducted at two study sites: Umeå and Malmö and the purpose of the study is to determine the effects of two novel protein hydrolysates on infants’ growth, neurological development, allergies, gastrointestinal symptoms and other health […]
Read More